iron hydroxide sucrose Tablets, chewable 500 mg

Dossier type
CTD
Dossier status
Under development
Country of origin
China
GMP approvals
FDA, EU GMP, PMDA, China
Manufacturer #17182
The company is an innovative pharmaceutical enterprise engaged in international competition, focusing on complex formulations, unique APIs, generics, and original new drugs to address unmet clinical needs globally. It has developed advanced drug technology platforms, including fermentation semi-synthesis, multi-chiral drug development, non-biological macromolecule production, drug-device combinations, and coupling drugs. The company specializes in therapeutic areas such as antifungal, antiviral, immunosuppression, oncology, cardiovascular, respiratory, and iron supplementation. Certified by GMP standards in China, the U.S., the EU, Japan, and South Korea, the company’s products are marketed worldwide, supported by a robust R&D foundation, global registration, and a comprehensive cGMP production system.

Manufacturer usually replies in nan days

None